Lv4
700 积分 2020-11-16 加入
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
1个月前
已关闭
Zorevunersen in Children and Adolescents with Dravet Syndrome
2个月前
已完结
Zorevunersen in Children and Adolescents with Dravet Syndrome
2个月前
已完结
The role of AP-1 in distinct cardiac cell types: Pathological repair and maladaptive remodeling
3个月前
已完结
B Cell-Mediated Autoimmune Diseases
3个月前
已关闭
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
4个月前
已完结
Tarlatamab: First Approval
1年前
已完结
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE®) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study
1年前
已完结
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
1年前
已完结
Obesity and Exercise: New Insights and Perspectives
3个月前
已采纳
Targeting MTAP increases PARP inhibitor susceptibility in triple-negative breast cancer through a feed-forward loop
1年前
已采纳
Engineering yeast subcellular compartments for increased production of the lipophilic natural products ginsenosides
1年前
已采纳
Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines
1年前
已采纳
ITGA5-Expressing Tumor Cells Interact with Schwann Cells to Drive Nerve Growth Factor-Mediated Immunosuppression of NK Cells
1年前
已采纳
ITGA5-Expressing Tumor Cells Interact with Schwann Cells to Drive Nerve Growth Factor-Mediated Immunosuppression of NK Cells
1年前
已采纳
Osteoarthritis gene therapy: Expanding the scope of genetic therapies
1年前
已采纳
Targeted Silencing of Engrailed-1 Reprograms Profibrotic Fibroblast Lineages for Scarless Wound Healing
1年前
已采纳
Oncolytic HSV and cancer drug interactions: Current clinical status and future directions
1年前
已采纳
Treatment of GATA2 deficiency by allele-specific CRISPR/Cas9-directed gene correction in hematopoietic stem cells
1年前
已采纳
皖公网安备34019202002308
